Additionally, GLP-1 has neurological effects that decrease appetite, increase satiety, and reduce the desire for food [1]
Fatigue and Dizziness General weakness, dizziness, and loss of energy are frequently reported, particularly during early dose titration
Indications (Research Use Only) As research protocols show, Retatrutide is being studied for the following potential indications: Obesity management: One of the primary areas of investigation is the treatment of obesity, particularly in individuals with a body mass index (BMI) above clinical thresholds that do not acquire substantial results through healthy diet or sport
Weight Loss Drugs May Not Be Eating Enough Nutritious Food
Track this carefully
Patients should discuss these symptoms with a qualified clinician, especially if they are persistent, worsening, or uncomfortable